The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Aurora Cannabis is a drug manufacturers - specialty & generic business based in the US. Aurora Cannabis shares (ACB) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $4.84 – an increase of 0.62% over the previous week. Aurora Cannabis employs 1,073 staff and has a trailing 12-month revenue of around $320.8 million.
| Latest market close | $4.84 |
|---|---|
| 52-week range | $3.42 - $8.14 |
| 50-day moving average | $4.59 |
| 200-day moving average | $5.10 |
| Wall St. target price | $32.07 |
| PE ratio | 23.75 |
| Dividend yield | N/A |
| Earnings per share (TTM) | $0.20 |
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $4.75 from 2025-05-01
| 1 week (2025-04-25) | -1.25% |
|---|---|
| 1 month (2025-04-03) | 10.72% |
| 3 months (2025-02-03) | 37.28% |
| 6 months (2024-11-01) | -14.26% |
| 1 year (2024-05-03) | -29.53% |
|---|---|
| 2 years (2023-05-03) | -21.28% |
| 3 years (2022-05-03) | 30.3 |
| 5 years (2020-05-01) | 84.372 |
Valuing Aurora Cannabis stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Aurora Cannabis's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Aurora Cannabis's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Aurora Cannabis shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Aurora Cannabis's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $61.7 million.
The EBITDA is a measure of a Aurora Cannabis's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $320.8 million |
|---|---|
| Operating margin TTM | 42.72% |
| Gross profit TTM | $211.8 million |
| Return on assets TTM | 2.79% |
| Return on equity TTM | 2.65% |
| Profit margin | 1.57% |
| Book value | $10.44 |
| Market Capitalization | $260.7 million |
TTM: trailing 12 months
We're not expecting Aurora Cannabis to pay a dividend over the next 12 months.
Aurora Cannabis's shares were split on a 1:10 basis on 19 February 2024 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aurora Cannabis shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aurora Cannabis shares which in turn could have impacted Aurora Cannabis's share price.
Over the last 12 months, Aurora Cannabis's shares have ranged in value from as little as $3.4216 up to $8.1409. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aurora Cannabis's is 2.878. This would suggest that Aurora Cannabis's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Aurora Cannabis Inc. , together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; supplies propagated vegetables and ornamental plants; and distributes and sells hemp-derived cannabidiol (CBD) products. The company also cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, dried flowers, vapes, dried milled strains, edibles, concentrates, and strain specific cannabis oils and extracts; and provides patient counseling and outreach services. Its adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
Track the progress of the S&P 500 stocks to make more informed investment decisions.
These are the stocks to buy when you don’t have much to spend.
These are the best day trading apps, according to Finder’s comprehensive analysis.
Explore the best bonuses for opening a new brokerage account.
Stock lending allows investors to loan out their existing stocks, although it has both advantages and disadvantages.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 7 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
Webull is a broker with zero-commission trading and a suite of tools to help you invest.